INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE

INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE

• Publication year

  2019

• Venue

  Biological Markers in Fundamental and Clinical Medicine (collection of abstracts)

• Publication date

  2019-11-07

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.29256/v.03.01.2019.escbm33
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.

  2016cited by this paper
• Betaine is a positive regulator of mitochondrial respiration.

  2015cited by this paper
• Consolidated and emerging inflammatory markers in coronary artery disease.

  2015cited by this paper
• Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease

  2012cited by this paper
• Comorbidity and guidelines: conflicting interests.

  2006cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper

• No citing papers are available for this paper.